French acquisition furthers E Merck's orthopaedics strategy
This article was originally published in Clinica
Executive Summary
E Merck (Germany) has purchased ProthAid, a French manufacturer and distributor of prostheses, orthopaedic screws and artificial cruciate ligaments, for an undisclosed sum. The company will be merged with Impact, another French prosthesis manufacturer in which E Merck took a majority stake in 1993, to form Merck Biomaterial France based in Valence. ProthAid, which employs 36 staff, had sales of Fr 82 million ($16 million) in 1994.
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.